Accuracy of Patient‐Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments
Findings From the Emerging Drugs Network of Australia
Bibliographic Data
Attendance · Drug · Harm reduction · Logistic regression · Odds · Odds ratio · Prescription Drug Misuse · Public health · Forensic Toxicology and Drug Analysis · Opioid Use Disorder Treatment · Poisoning and overdose treatments
Drug checking services for people who use drugs
The Redcap consortium
Stigma, and factors associated with experiencing stigma, while visiting health‐care services among samples of people who use illegal drugs in Australia
Adulteration and substitution of drugs purchased in Australia from cryptomarkets
The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction—A Narrative Review
The Need to Revitalise Drug Use Monitoring to Keep Pace With a More Dynamic, Digitally Enabled and Globally Connected Drug Market
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)‐related death in Australia, 2001–2023
Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia
Intentions, actions and outcomes
Novel psychoactive substances in Australian emergency departments
The stigmatisation of ‘ice’ and under-reporting of meth/amphetamine use in general population surveys
Predictors of using social media to purchase drugs in New Zealand
| Citation velocity | historical |
|---|---|
| Highly cited | No |